Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Medivation Inc    MDVN

Delayed Quote. Delayed  - 09/27 10:14:59 pm
81.44 USD   +0.02%
10/09 MEDIVATION : New Data Presented at ESMO 2016 Further Demonstrates XT..
09/28 PFIZER INC. (NY : PFE) Acquisition Of Medivation, Inc. (NASDAQ:MDVN)..
09/28 Xenon Pharmaceuticals Appoints Dawn Svoronos to Its Board of Dire..
News SummaryMost relevantAll newsSector news 

Medivation Inc : Medivation Announces Participation at Upcoming Investor Conferences

share with twitter share with LinkedIn share with facebook
share via e-mail
10/30/2013 | 10:34pm CEST

SAN FRANCISCO, CA -- (Marketwired) -- 10/28/13 -- Medivation, Inc. (NASDAQ: MDVN) today announced that it will host a live teleconference with management to discuss third quarter 2013 financial results and provide a general business update on November 12, 2013 at 4:30 p.m. Eastern Time. A press release for the third quarter of 2013 will be released after markets close on November 12, 2013.

Interested parties may listen to the live teleconference by calling 877-303-2523 from the U.S. or +1-253-237-1755 internationally. Individuals may access the live audio webcast by visiting: http://investors.medivation.com/events.cfm.

About Medivation
Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel therapies to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their families. For more information, please visit us at www.medivation.com.

Patrick Machado
Chief Business & Financial Officer
(415) 829-4101

Anne Bowdidge
Sr. Director, Investor Relations
(650) 218-6900

Source: Medivation

News Provided by Acquire Media

distributed by
share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on MEDIVATION INC
10/09 MEDIVATION : New Data Presented at ESMO 2016 Further Demonstrates XTANDITM▼..
10/06 PFIZER : Completes Acquisition of Medivation
09/28 MEDIVATION, INC. : Termination of a Material Definitive Agreement, Completion of..
09/28 PFIZER INC. (NYSE : PFE) Acquisition Of Medivation, Inc. (NASDAQ:MDVN) To Close ..
09/28 Xenon Pharmaceuticals Appoints Dawn Svoronos to Its Board of Directors
09/28 MEDIVATION : Highlights New Data From Differentiated Oncology Portfolio at ESMO ..
09/26 PFIZER : Announces Expiration of HSR Waiting Period For Proposed Acquisition of ..
09/26DJPfizer Throws Out Plan to Split Into Two Companies
09/23 PFIZER : expects to close Medivation buyout in 3Q
09/20 MEDIVATION : One of these five firms could be the next big thing in the life sci..
More news
Sector news : Bio Therapeutic Drugs
10/21DJU.S. HOT STOCKS : Hot Stocks to Watch
10/20DJALKERMES : Shares Surge
10/20 ACTELION : raises guidance for third time this year on strong PAH sales
10/18 Pfizer to start shipping biosimilar version of J&J's Remicade in November
10/17DJPfizer Plans to Launch Remicade Biosimilar in November
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
10/18 M&A Gives Signs Of Reverting To The Mean
10/12 Pfizer's Growth Strategies May Need More Than Just Small Acquisitions
10/10 Lively M&A Scene Keeps Biotech Shares Buoyant In Q3
10/08 MARKETPLACE ROUNDTABLE : Sifting The World And The M&A Market
10/05 Global M&A Drops In 3rd Quarter, Companies Wary Of Overpaying
Financials ($)
More Financials
Duration : Period :
Medivation Inc Technical Analysis Chart | MDVN | US58501N1019 | 4-Traders
Full-screen chart
Technical analysis trends MEDIVATION INC
Short TermMid-TermLong Term
Technical analysis
Income Statement Evolution
More Financials
Mean consensus
Number of Analysts
Average target price -
Spread / Average Target
Consensus details
EPS Revisions
More Estimates Revisions
David T. Hung Chief Executive Officer & Director
Douglas E. Giordano President, Director & Treasurer
Marion McCourt Chief Operating Officer
Jennifer Jarrett Chief Financial Officer
Mohammad Hirmand Chief Medical Officer
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
AMGEN, INC.-2.35%118 623
GILEAD SCIENCES, INC.-26.58%98 037
More Results